Company intelligence / Profile preview

Ademtech

Pessac, Nouvelle-Aquitaine, Franceademtech.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Ademtech has developed proprietary superparamagnetic nanoparticle technologies used in a range of commercial products for DNA/RNA extraction, normalization kits, PCR kits for infectious disease detection (e.g., mycology), and cell/molecule/virus separation. The company’s solutions are widely adopted by the IVD industry and life science researchers. No clinical trial results as the company focuses on tools/reagents rather than therapeutics.

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceNanoparticlePolymer-based technology
Industry: Molecular Diagnostics

Partnerships

Not explicitly listed; likely collaborates with academic institutions such as CNRS Bordeaux based on origin of core technologies.

Beyond the preview

Go deeper on Ademtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ademtech.

Explore the full profile